Search results
Novartis (NVS) Reports Positive Long-Term Data on CSU Drug
Zacks via Yahoo News· 1 month agoNovartis NVS announced new long-term efficacy and safety data from the late-stage studies REMIX-1...
Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
Zacks via Yahoo News· 2 months agoSanofi (SNY) and Regeneron's (REGN) Dupixent is poised to be the first medicine for adolescents with...
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Zacks via Yahoo News· 3 months agoThe first-quarter 2024 earnings season picked up pace this week, with Merck MRK, Sanofi SNY,...
Sanofi (SNY) Rilzabrutinib Shows Benefit in Blood Disorder Study
Zacks via Yahoo News· 3 months agoSanofi's (SNY) BTK inhibitor, rilzabrutinib, demonstrates durable platelet response in the phase III...
Roche's (RHHBY) Xolair Gets Approval for Food Allergies
Zacks via Yahoo News· 5 months agoRoche RHHBY announced that the FDA has approved a label expansion of the asthma drug Xolair...
Jasper Therapeutics (JSPR) Surges 110% in a Month: Here's Why
Zacks via Yahoo News· 6 months agoJasper Therapeutics (JSPR) surges after it provides business updates that highlight the company's...
Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update
Zacks via Yahoo News· 6 months agoIt was a low-key week for the biotech sector with no major updates. Regulatory and pipeline updates...
Reasons to Add Blueprint (BPMC) Stock to Your Portfolio Now
Zacks via Yahoo News· 6 months agoBlueprint Medicines Corporation BPMC is focused on developing transformational precision medicines...
Roche's (RHHBY) sBLA for Xolair Gets FDA Priority Review Tag
Zacks via Yahoo News· 7 months agoThe FDA accepts and grants priority review to Roche's (RHHBY) supplemental biologics license...
Novartis (NVS) Raises Mid-Term Sales Outlook; Outlines Strategy
Zacks via Yahoo News· 8 months agoSwiss pharma giant Novartis NVS raised its sales and operating income goals for the mid-term, post...